Skip to main content Back to Top
Advertisement

3/6/2020

Tuberculin

Reason for the Shortage

    • Par has Aplisol available.
    • Sanofi Pasteur has Tubersol available.

Available Products

    • Aplisol injection, Par Pharmaceuticals, 5 TU/0.1 mL, 1 mL multiple dose vial, NDC 42023-0104-01
    • Aplisol injection, Par Pharmaceuticals, 5 TU/0.1 mL, 5 mL multiple dose vial, NDC 42023-0104-05
    • Tubersol injection, Sanofi Pasteur, 5 TU/0.1 mL, 1 mL multiple dose vial, NDC 49281-0752-21
    • Tubersol injection, Sanofi Pasteur, 5 TU/0.1 mL, 5 mL multiple dose vial, NDC 49281-0752-22

Estimated Resupply Dates

    • All presentations are available.

Implications for Patient Care

    • CDC has additional information regarding the anticipated tuberculin shortage as well as management strategies on their website at https://emergency.cdc.gov/han/han00420.asp. The supply interruption is estimated to begin in June 2019 and continue for approximately 3 to 10 months

Updated

Updated March 6, 2020 by Anthony Trovato, PharmD, BCPS. Created June 12, 2019 by Megan Dryer, PharmD. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.
ADVERTISEMENT